Intuitive Surgical's Q4 revenue rises 19%, EPS beats estimates

Intuitive Surgical

22/01/2026 21:14

Overview

Surgical robots maker's Q4 revenue rose 19%, driven by increased procedure volume

Adjusted EPS beat analysts' expectations

Adjusted net income exceeded analysts' estimates

Outlook

Intuitive expects worldwide da Vinci procedure growth of 13% to 15% in 2026

Company forecasts non-GAAP gross profit margin between 67% and 68% for 2026

Intuitive anticipates non-GAAP operating expense growth of 11% to 15% in 2026

Result Drivers

PROCEDURE GROWTH - Worldwide procedures grew 18%, with da Vinci up 17% and Ion up 44%

SYSTEM PLACEMENTS - Da Vinci system placements increased to 532, including 303 da Vinci 5 systems

INSTALLED BASE EXPANSION - Da Vinci installed base grew 12% and Ion by 24%

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Adjusted EPS
Beat
$2.53
$2.26 (24 Analysts)
Q4 EPS
$2.21
Q4 Adjusted Net Income
Beat
$914 mln
$814.97 mln (21 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 20 "strong buy" or "buy", 13 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Intuitive Surgical Inc is $612.50, about 17% above its January 21 closing price of $523.69

The stock recently traded at 54 times the next 12-month earnings vs. a P/E of 50 three months ago

Press Release: ID:nGNX6n9xZG

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)